The Justice Department and Drug Enforcement Administration announced April 23 that FDA-approved marijuana products and medical marijuana products covered by a qualifying state-issued license have been moved to Schedule III of the Controlled Substances Act, a significant loosening of federal restrictions on the drug for medical use.
The order, issued by Acting Attorney General Todd Blanche, carries out President Donald Trump's Dec. 18, 2025 executive order calling for expanded research into medical marijuana and cannabidiol.
Recent comments
2 days 55 min ago
4 days 1 hour ago
4 days 2 hours ago
4 days 4 hours ago
2 weeks 1 day ago
18 weeks 3 days ago
18 weeks 6 days ago
27 weeks 2 hours ago
28 weeks 1 day ago
28 weeks 6 days ago